⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Official Title: A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Study ID: NCT00831636

Conditions

Ovarian Cancer

Interventions

CP-4055
CP-4055

Study Description

Brief Summary: This is non randomised, open label, dose finding, efficacy and safety study, enrolling patients with advanced (stage III and IV) ovarian cancer It will be conducted in two successive phases. Phase II has a two-step design

Detailed Description: Phase I * Three eligible patients will be enrolled at each dose level (DL), according to standard dose escalation decision rules * Patients will receive CP-4055 at increasing DLs until the maximum tolerated dose and the recommended dose (RD) have been established Phase II * Step 1 (The patient inclusion may stop after this step): * Patients will be enrolled at the RD until there are maximum 16 evaluable patients at this DL * Step 2: * Depending on the response rate at step 1, up to 26 patients will be included and treated at step 2

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

U.Z. Gasthuisberg, Gynecologic Oncology, Herestraat 49, Leuven, , Belgium

Medical Oncology C, National Cancer Institute, Centro di Riferimento Oncologico, Aviano (PN), , Italy

Medical Oncology B, National Cancer Institute, Via Mariano Semmola, Naples, , Italy

Department of Oncology, Catholic University of the Sacred Heart, Rome, , Italy

Medical Oncology, Fatebenefratelli Hospital, Isola Tiberina, Rome, , Italy

Contact Details

Name: Sandro Pignata, MD

Affiliation: Medical Oncology B, National Cancer Institute, Via Mariano Semmola, IT-80131 Naples, Italy

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: